Remove 2050 Remove Cannabinoids Remove Policy Remove Treatment
article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Access to treatment. Daniel Perkins a b Hugh Brophy a Iain S. Medicinal cannabis. Road safety.

article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia. methadone) demonstrate a feasible alternative approach. Conclusion.

Policy 66